Preparing for Open Enrollment, Part II: Policy Updates and Account Tune Ups
Resource updated 06/13/2023
Resource updated 06/13/2023
Resource (Conference Presentation) updated 09/14/2023
Use of patient-reported outcome measures (PROMS) and patient-reported experience measures (PREMS) to help guide quality improvement activities by utilizing the patient voices and input.
Resource (Conference Presentation) updated 09/14/2023
Update on federal and state healthcare and health coverage policies impacting RWHAP agencies.
Resource (Conference Presentation) updated 09/14/2023
In-depth review of Policy Clarification Notice 15-02 requirements for performance measurement.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 10/24/2023
Resource updated 05/11/2023
Resource updated 12/19/2023
Resource updated 10/18/2023
Resource updated 05/10/2023
Blog updated 05/11/2023
Resource updated 06/27/2024
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
Resource updated 09/14/2023
Blog updated 02/28/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023